Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (20)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. 25-Hydroxyvitamin D Serum Levels Linked to Single Nucleotide Polymorphisms (SNPs) (rs2228570, rs2282679, rs10741657) in Skeletal Muscle Aging in Institutionalized Elderly Men Not Supplemented with Vitamin D

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience

    Cancers, Vol. 14, Núm. 7

2021

  1. Long COVID a new derivative in the chaos of SARS-CoV-2 infection: The emergent pandemic?

    Journal of Clinical Medicine, Vol. 10, Núm. 24

2020

  1. Liquid biopsy as novel tool in precision medicine: Origins, properties, identification and clinical perspective of cancer’s biomarkers

    Diagnostics, Vol. 10, Núm. 4

2019

  1. Neurological disorders in central Spain, second survey: Feasibility pilot observational study

    Journal of Medical Internet Research, Vol. 21, Núm. 1

2017

  1. Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors

    Scientific Reports, Vol. 7

  2. Delta-amino-levulinic acid dehydratase gene and essential tremor

    European Journal of Clinical Investigation, Vol. 47, Núm. 5, pp. 348-356

  3. Effect of the Fat Component of Dairy Products in Cardiovascular Health, Vascular Structure and Function

    Nutrients in Dairy and Their Implications for Health and Disease (Elsevier), pp. 325-332

2016

  1. Association between different risk factors and vascular accelerated ageing (EVA study): Study protocol for a cross-sectional, descriptive observational study

    BMJ Open, Vol. 6, Núm. 6

  2. Serum Superoxide Dismutase Is Associated with Vascular Structure and Function in Hypertensive and Diabetic Patients

    Oxidative Medicine and Cellular Longevity, Vol. 2016

2015

  1. Plasma cardiotrophin-1 as a marker of hypertension and diabetes-induced target organ damage and cardiovascular risk

    Medicine (United States), Vol. 94, Núm. 30

2013

  1. No association of the SLC1A2 rs3794087 allele with risk for essential tremor in the Spanish population

    Pharmacogenetics and Genomics, Vol. 23, Núm. 11, pp. 587-590

2012

  1. Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study

    Movement Disorders, Vol. 27, Núm. 2, pp. 211-218

  2. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes

    European Journal of Clinical Investigation, Vol. 42, Núm. 5, pp. 548-556

2010

  1. Afección renal subclínica y establecida en pacientes hipertensos de nuevo diagnóstico

    Medicina Clinica, Vol. 134, Núm. 6, pp. 246-253

  2. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

    BMC Medicine, Vol. 8

2009

  1. Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organ damage in hypertensive patients (LOD-RISK study)

    Blood Pressure Monitoring, Vol. 14, Núm. 4, pp. 145-151

  2. Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients

    BMC Cardiovascular Disorders, Vol. 9